Revonto® (Dantrolene Sodium) 20mg Vial, 6/Box

In Stock
In Stock
In Stock
Revonto is indicated, along with appropriate supportive measures, for the management of fulminant hypermetabolism of skeletal muscle characteristic of malignant hyperthermia crises in patients of all ages. It is also indicated preoperatively and sometimes postoperatively, to prevent or attenuate the development of clinical and laboratory signs of malignant hyperthermia in individuals judged to be malignant hyperthermia susceptible.
  • For Intravenous use only

NDC: 27505-003-67

More Information
Brand US WorldMeds
Strength 20 mg
Delivery Method Vial
Count 6/Box
Drug Category Autonomic Drugs